High-Grade Salivary Gland Cancer Cell Types
High-grade salivary gland cancers include salivary duct carcinoma, high-grade mucoepidermoid carcinoma, solid-type adenoid cystic carcinoma, carcinoma ex pleomorphic adenoma, and high-grade transformation of low/intermediate-grade carcinomas. 1
Primary High-Grade Salivary Carcinoma Types
Definitively High-Grade Types
Salivary Duct Carcinoma (SDC)
High-Grade Mucoepidermoid Carcinoma
- Graded in a three-tier system based on:
- Cystic component
- Border characteristics
- Mitotic activity
- Cellular anaplasia
- Perineural invasion 4
- High-grade variants have poor prognosis
- Graded in a three-tier system based on:
Solid-Type Adenoid Cystic Carcinoma
Carcinoma ex Pleomorphic Adenoma (High-Grade)
Adenocarcinoma Not Otherwise Specified (NOS)
- Now termed "salivary carcinoma, NOS"
- High-grade variants have >20% rate of clinically positive nodal involvement 3
High-Grade Transformation
Several salivary gland tumors can undergo high-grade transformation:
- Low or intermediate-grade tumors that transform to high-grade carcinomas
- Adenoid cystic carcinomas may transform to pleomorphic high-grade carcinomas
- This transformation confers high propensity for lymph node metastasis 4
- Secretory carcinomas with high-grade transformation may be candidates for anti-TRK therapy 1
Clinical Implications of High-Grade Status
The identification of high-grade salivary carcinomas has significant treatment implications:
Surgical Management
Neck Management
Adjuvant Therapy
Diagnostic Challenges
Accurate grading is essential but challenging due to:
- Histologic overlap between different tumor types
- Morphologic heterogeneity within tumors
- Rarity of these tumors 1
Detailed histological evaluation with adequate sampling and appropriate molecular ancillary tests is crucial for proper diagnosis and treatment planning 1.
Treatment Considerations
Treatment decisions should be based on both histologic grade and clinical stage:
- Even for stage I high-grade tumors with complete resection, close follow-up is essential
- For stage II-IV high-grade tumors, multimodality treatment with surgery and radiation is standard 3
- Targeted therapies may be available for specific high-grade subtypes (e.g., androgen deprivation and anti-HER2 therapies for salivary duct carcinoma) 1
Regular follow-up is critical as approximately 70% of recurrences of high-grade malignant salivary gland tumors occur within the first 3 years after treatment 3.